Immunophenotyping is an important component in the evaluation of lymphoid lesions identified in cytologic samples. Traditionally, phenotyping of cell surface antigens is achieved by the use of flow cytometry (FC). However, FC requires relatively large quantities of cells, which may limit its application to cytologic samples. As an alternative, immunophenotypes can be obtained by the use of laser scanning cytometry (LSC).
The immunophenotype of lymphoid cytologic samples obtained by laser scanning cytometry (LSC) and flow cytometry (FC) was compared in 72 cases composed of a series of 23 cases with simultaneous LSC and FC immunophenotyping and a second series of 49 cases in which nonsimultaneous immunophenotyping was performed. In both series, no discordance in the population immunophenotype was found that would result in changes in diagnostic classification, although minor discordance in some antigens was found, predominantly affecting FMC7, CD11c, and CD23. The immunophenotype obtained by LSC shows a high degree of concordance with that obtained by FC and generates results that are diagnostically equivalent. Potential explanations for the discordant markers include differences related to the techniques, differences in the fluorochrome-labeled antibodies, technical factors, differences in antigen expression related to anatomic sites, temporal variations, and interpretive variances.
Immunophenotyping is an important component in the evaluation of lymphoid lesions identified in cytologic samples. Traditionally, phenotyping of cell surface antigens is achieved by the use of flow cytometry (FC). However, FC requires relatively large quantities of cells, which may limit its application to cytologic samples. As an alternative, immunophenotypes can be obtained by the use of laser scanning cytometry (LSC).
LSC uses an optical microscope to examine cellular samples deposited on a specially modified glass microscope slide. Similar to FC, an argon laser and fluorochrome-conjugated antibodies are used to detect cell surface antigens, but LSC differs from FC in the use of image analysis to identify events. Clatch et al 1 described a method of LSC immunophenotyping using fresh, unfixed cells and forward light scatter as the contouring parameter to define events and obtained immunophenotypes from a variety of samples.
LSC is able to obtain an immunophenotype using small quantities of cells, allowing application to paucicellular cytologic samples and reducing immunophenotyping costs by a reduction in the amount of conjugated antibodies consumed. 2, 3 Furthermore, the cells in LSC immunophenotyping are deposited on a glass slide and remain stationary, allowing repetitive scanning, relocalization, and visualization of the events. [2] [3] [4] [5] [6] If necessary, restaining may be performed of the cells in lanes with negative results to detect additional cell surface markers or, after fixation and permeabilization of the cytoplasmic membrane, restaining can be used for the assessment of intracellular antigens.
Although LSC is established as a method for obtaining immunophenotypic data, direct comparison of the immunophenotype obtained from LSC with that obtained from FC on cytologic samples has not been extensively investigated.
Materials and Methods
After obtaining institutional ethics approval, the cases used in the study were derived from 2 sources. The first series of cases was obtained from cytologic samples that had undergone simultaneous immunophenotyping by LSC and FC (simultaneous group). This was performed in part as a validation study during introduction of LSC immunophenotyping and as subsequent quality assurance assessments. The second series of cases was derived from a retrospective collection of cases in which cytologic samples had undergone LSC immunophenotyping and in which preceding or subsequent FC immunophenotyping was performed on a different sample within 90 days of the LSC. In the cases of nonsimultaneous immunophenotyping, the cases were further subdivided into those in which the same anatomic site was sampled on each occasion (nonsimultaneous, same anatomic site [NSSA]) and cases in which different anatomic sites were sampled (nonsimultaneous, different anatomic site [NSDA] ). In all of the nonsimultaneous immunophenotyping cases, the FC could have been performed on a cytologic or surgical pathology sample. The NSDA cases had to demonstrate an abnormal phenotype to be included in the study to try to reduce sampling errors.
LSC immunophenotyping was performed following the Clatch protocol 7 using the laser scanning cytometer (CompuCyte, Cambridge, MA) and WinCyte software (CompuCyte) with events contoured on the basis of forward light scatter. A standard 12-lane Clatch slide was used containing the following antibody combinations: CD45/negative control, CD45/CD3/C20, CD45/CD19/CD5, CD45/CD19/CD10, CD45/CD20+CD19/polyclonal κ, CD45/CD20+CD19/polyclonal λ, CD45/CD22/CD23, CD45/FMC7/CD25, CD45/ CD4/CD8, CD45/CD7/CD56, CD45/CD16/CD2, and CD45/ CD11c/CD14. The antibody clones, fluorochromes, and suppliers are listed in zTable 1z. The antibodies were diluted at 1:10 concentrations in phosphate-buffered saline (PBS). A minimum of 2,000 events were scanned in each lane.
FC was performed on samples processed using a whole blood lysis technique. The sample was first filtered through 70-µm nylon mesh cell strainers (Becton Dickinson Labware, Franklin Lakes, NJ), washed once with PBS, and resuspended in 5% human albumin to a concentration of approximately 5 to 20 × 10 9 /L. Selected antibodies conjugated to fluorescein isothiocyanate, phycoerythrin, phycoerythrin-Texas Red-x, and phycoerythrin-cyanin 5.1 were used at concentrations titrated for optimal staining. We added 100 µL of the cell suspension to tubes containing the fluorochrome-conjugated antibodies and incubated them for 15 minutes at room temperature in the dark. After incubation, OptiLyse C (Beckman Coulter, Miami, FL), a fixative and lysing agent, was added to each tube. Following 10 minutes' incubation with OptiLyse C, the sample was washed once with PBS, decanted, and reconstituted in 5% human albumin. The immunophenotyping was performed by multiparameter FC (Cytomics FC-500, Beckman Coulter). The events were gated using forward scatter vs side scatter. The following panels were used for FC immunophenotypic analysis: CD19/monoclonal κ/monoclonal λ, CD5/CD10/CD20, CD23/FMC7/CD19, CD4/CD8/ CD3, CD2/CD7/CD11c, CD11c/CD20/CD45, and an autofluorescent negative control sample.
No attempt was made to coordinate the antibody panels used for LSC and FC, and immunophenotypic evaluation was performed independently and in a blinded manner. Discordance was defined as a positive marker as detected by one of the techniques and a negative marker in the other as determined by visual assessment of the histograms and comparing them with their own controls. The intensity of antigen expression was not compared between LSC and FC. The immunophenotypes were compared for the population in general and for the specific markers used in both procedures, ie, κ, λ, CD19, CD20, CD10, CD23, FMC7, CD11c, CD2, CD3, CD5, CD4, CD7, and CD8. In cases in which a discordance was present following original evaluation, the LSC and FC results were rereviewed in a blinded manner to try to reduce interpretive errors, with the results of the final review used for analysis.
Results
We identified 72 cases from 68 patients that met the inclusion criteria, including 66 fine-needle aspiration specimens, 5 effusion samples, and 1 bronchoalveolar lavage fluid sample zTable 2z. The average age for the patient population was 55.5 years with an age range of 17 to 85 years and a male/female ratio of 2.6:1. Of the cases, 23 had simultaneous LSC and FC; 49 cases had nonsimultaneous LSC and FC. The nonsimultaneous category included 43 cases in the NSSA category and 6 cases in the NSDA category. In 43 samples (40 NSSA and 3 NSDA), the LSC preceded the FC, and in 6 cases (3 NSSA and 3 NSDA), LSC followed FC immunophenotyping. In the NSSA group, FC immunophenotyping was performed on surgical pathology samples in 40 cases and cytologic samples in 3 cases. In the NSDA group, FC immunophenotyping was performed on 4 surgical pathology samples and 2 cytologic samples.
LSC and FC confirmed the same population immunophenotype in all 23 cases of the simultaneous group, with 6 cases demonstrating a "reactive" immunophenotype and 17 cases with an abnormal immunophenotype. For the specific markers, there were 250 correlative markers and 7 noncorrelative markers zTable 3z. FMC7 was the only marker that did not correlate on 3 occasions. CD10, CD2, CD5, and CD11c did not correlate on 1 occasion each.
In CD19  42  42  100  CD20  43  43  100  CD10  40  41  98  CD23  27  30  90  FMC7  29  33  88  CD2  29  29  100  CD3  39  39  100  CD5  37  38  97  CD4  35  35  100  CD7  31  31  100  CD8  35  35  100  CD11c  23  27  85 correlative between LSC and FC and only 2 noncorrelative markers zTable 5z. FMC7 and CD11c did not correlate on one occasion each. When all data were combined, there were 820 correlating markers and 24 noncorrelative markers, and none of the noncorrelative markers resulted in a change in the diagnostic classification of the lymphoma. FMC7, CD23, and CD11c were the markers most commonly found to be noncorrelative, and, on most occasions, FC showed expression of the antigen with the exception of 2 cases in which the antigen was assessed as present by LSC but absent by FC zTable 6z.
Discussion
Next to morphologic assessment, immunophenotyping is critical in the evaluation of lymphoid lesions. Traditionally, it has been achieved through immunophenotyping of cell surface antigens by immunoperoxidase staining or by FC for greater sensitivity and range of antigens detected. An alternative method to FC is LSC, which is similar to FC in many aspects. Both techniques measure forward light scatter characteristics and use a multiparametric approach to evaluate the emitted fluorescence from fluorochrome-conjugated antibodies directed toward specific cell surface antigens. Both techniques are automated and equally rapid, generating data in list-mode files in FC standard format. LSC differs from FC in that the cells are retained on a glass slide and the cell position data are retained, allowing direct visualization of the cells of interest, repeated scanning, and, potentially, restaining, 2,3,6 but it is important to note that LSC can obtain a detailed immunophenotype using very few cells, making it ideally suited for cytologic samples that may have low cellularity. In this study, we wanted to determine the comparability of LSC and FC immunophenotypes specifically for cytologic samples.
On the level of whole population analysis, our series found that the immunophenotype obtained by LSC was similar to that obtained by FC despite the use of different antibody clones and conjugates in the 2 methods. Our findings are in keeping with reports in literature in which LSC has been found to demonstrate immunophenotypes comparable to those determined by FC. In a study similar to ours but including a wide variety of sample types and restricted to cases with hematologic abnormalities, Clatch et al 8 concluded that in all cases in which LSC and FC were performed simultaneously on the same sample, the results were "virtually" identical. However, some noncorrelative markers have been found, with FMC7, CD23, and CD11c most commonly implicated in our series. Although the discordance in these antigens did not affect the overall interpretation of the cases, their origins merit attention.
From our series, it is not possible to establish the cause of discordance with certainty. In the simultaneously immunophenotyped samples, potential sources of discordance include differences related to the instruments, differences in the fluorochrome-labeled antibodies, and technical factors. In the nonsimultaneously immunophenotyped cases, further potential causes for antigen variations must be considered, including differences in antigen expression related to anatomic sites and temporal variations in antigen expression. In both groups, the possibility of interpretive variations as a source of discordance must be considered.
The discordance in our series may relate to differences in the techniques themselves, with sensitivity of detection and dynamic range of the instruments potential culprits. In our series, the majority of discordance occurred when an antigen was detected by FC but not by LSC. This finding raises the possibility that differences in instrument sensitivity may account for the discordance. It has been reported that LSC may be limited in the detection of low-density antigens when immunophenotyping peripheral blood leukocytes. 9 However, not all cases of discordance were the result of detection of the antigen by FC and not LSC, suggesting that differences in the antibodies themselves could be a source of discordance. In this series, no attempt was made to duplicate the fluorochrome conjugates or antibody clones used in FC and LSC. Variations in the antibody clones could change the sensitivity for detection of the antigens as a result of differences in the epitope recognized, antibody binding, or, potentially, the conjugate properties. We believe the variation in antibodies is the most likely explanation for the discordance in the simultaneously immunophenotyped group in which the same specimen was divided between LSC and FC.
Clearly, some technical issues caused some of the discordance observed in our series. This is illustrated by the occurrence of nonspecific antibody binding that precluded assessment of surface light chain expression by FC, which was shown to be light chain restricted by LSC in a case of diffuse large B-cell lymphoma. Nonspecific antibody binding is a known artifact that can be caused by many factors in the process of preparing the specimens and when there is abundant necrosis. The loss of cytoplasm from the cells of a large B-cell lymphoma during sample preparation is another known artifact that was reported in the literature affecting LSC and FC. [10] [11] [12] Minor antigen discordance as seen in our series during immunophenotyping is well recorded for non-Hodgkin lymphoma. [12] [13] [14] Similar to our series, the antigens most commonly discordant have been CD5, CD10, CD23, and FMC7. It has been proposed that some of these discordant findings arise from antigenic variation relating to differences in anatomic sites sampled when assessed by simultaneous FC immunophenotyping. [13] [14] [15] In our series of nonsimultaneous immunophenotyping, even within the NSSA cases in which it appeared that the same anatomic lesion had been targeted by both samples, it cannot be ensured that the same lesion was sampled on both occasions, and observed discordance may result from sample and anatomic variations.
Temporal variations in immunophenotype may also occur [16] [17] [18] [19] and could explain antigen variation in samples obtained at different times. It has been shown that CD5, CD10, CD11c, CD19, CD20, CD21, CD22, CD23, and CD25 show variability between samples obtained from the same patient at different times with antigens involved in B-cell activation, such as CD23, showing greater variability. 20 In our study, we accepted a maximum window of 90 days between samples to try to reduce the influence of temporal variation and preclude changes in immunophenotype that may have arisen from treatment effects or potential transformation of lymphoma cases.
Finally, the subjective nature of the interpretation of immunophenotypes is a potential cause for the discordance of some markers. In our study, we undertook a blinded secondary review to try to reduce the potential for interpretive errors, but subjectivity cannot be eliminated. However, despite minor discordance in some markers, the immunophenotype obtained by LSC on cytologic samples showed a high degree of concordance with that obtained by FC and generated results that were diagnostically equivalent.
